SCHEMBL646013

SCHEMBL646013

[CH]1CCC(C(CCc2ccccc2)N2CCCCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
TSHR P16473 2/20 0.41
CYP2C19 P33261 1/20 0.41
SLC6A3 Q01959 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
SLC18A2 Q05940 1/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A2 P23975 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644191 0.86 POLB (0.42) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL493284 0.84 SIGMAR1 (0.41) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL645172 0.84 ACE (0.41) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL643236 0.83 ACE (0.40) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL642907 0.81 SLC6A3 (0.37) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL644061 0.80 ACE (0.38) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL644331 0.80 ALDH1A1 (0.38) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL644641 0.79 KMT2A (0.41) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL644224 0.78 HTT (0.40) SIGMAR1TSHRSLC6A3MEN1KMT2A
SCHEMBL646835 0.77 KDM4E (0.34) SIGMAR1CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119633-B2 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed